DUBLIN--(BUSINESS WIRE)--
Research and Markets has announced the addition of the "Global Drug Addiction Partnering 2010 to 2016" report to their offering.
The Drug Addiction Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
Global Therapy Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:
Key Topics Covered:
Executive Summary
1 Therapy partnering trends in numbers
2 Most active dealmakers
3 Partnering deals directory
4 Partnering deals with a contract document
5 M&A in numbers
6 M&A deals directory
7 Financing in numbers
8 Financing deals directory
For more information about this report visit http://www.researchandmarkets.com/research/bl98hj/global_drug

View source version on businesswire.com: http://www.businesswire.com/news/home/20161207005773/en/